Cardinal Health, Inc. (CAH): Price and Financial Metrics

Cardinal Health, Inc. (CAH)

Today's Latest Price: $55.24 USD

0.24 (-0.43%)

Updated Jan 27 2:47pm

Add CAH to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 77 in Medical - Services

See all "A" rated Strong Buy stocks

CAH Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for CAH is 108.75 -- better than 99.86% of US stocks.
  • With a price/sales ratio of 0.11, Cardinal Health Inc has a higher such ratio than only 1.83% of stocks in our set.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 30.42 for Cardinal Health Inc; that's greater than it is for 98.85% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Cardinal Health Inc are EXTR, HYRE, NSP, CLPT, and REED.
  • CAH's SEC filings can be seen here. And to visit Cardinal Health Inc's official web site, go to

CAH Stock Price Chart Interactive Chart >

Price chart for CAH

CAH Price/Volume Stats

Current price $55.24 52-week high $60.69
Prev. close $55.48 52-week low $39.05
Day low $54.71 Volume 1,466,509
Day high $55.62 Avg. volume 1,740,030
50-day MA $54.69 Dividend yield 3.5%
200-day MA $52.01 Market Cap 16.21B

Cardinal Health, Inc. (CAH) Company Bio

Cardinal Health provides pharmaceutical and medical products and services that help pharmacies, hospitals and other healthcare providers focus on patient care. The company was founded in 1979 and is based in Dublin, Ohio.

CAH Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$55.24$85.41 54%

Below please find a table outlining a discounted cash flow forecast for CAH, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Cardinal Health Inc ranked in the 61th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 54.5% on a DCF basis. In terms of the factors that were most noteworthy in this DCF analysis for CAH, they are:

  • The stock's equity weight, or the proportion of capital from equity relative to debt, is 71. Notably, its equity weight is greater than merely 21.92% of US equities in the Healthcare sector yielding a positive free cash flow.
  • Cardinal Health Inc's weighted average cost of capital (WACC) is 8%; for context, that number is higher than merely 9.09% of tickers in our DCF set.
  • Cardinal Health Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CAH, try ANIP, RDNT, MCK, ANTM, and DGX.

CAH Latest News Stream

Event/Time News Detail
Loading, please wait...

CAH Latest Social Stream

Loading social stream, please wait...

View Full CAH Social Stream

Latest CAH News From Around the Web

Below are the latest news stories about Cardinal Health Inc that investors may wish to consider to help them evaluate CAH as an investment opportunity.

Cardinal Health, Inc.'s (NYSE:CAH) Intrinsic Value Is Potentially 20% Below Its Share Price

Today we will run through one way of estimating the intrinsic value of Cardinal Health, Inc. ( NYSE:CAH ) by taking the...

Yahoo | January 25, 2021

3 Cheap Dividend Aristocrats to Buy Right Now

Investors love dividend stocks because they allow you can generate cash flow from your investments without having to sell a single share. Dividends are not guaranteed, and investors learned that the hard way during the pandemic, as many stocks slashed their dividend payments amid the challenging economic conditions. Dividend Aristocrats are income-generating stocks that have not just paid but increased their dividend payments for at least 25 years in a row.

Yahoo | January 22, 2021

Barclays Stick to Their Buy Rating for Cardinal Health By

Barclays Stick to Their Buy Rating for Cardinal Health | January 17, 2021

Cardiac Catheters Market to Witness Huge Growth by 2026| Boston Scientific, Cordis(Cardinal health), Abbott, BBRAUN, Medtronic, Terumo, Teleflex, C. R. Bard, Edwards, Cook, Merit Medical, Biotronik, St.Jude Medical, BALT, Osypka AG, Japan Lifeline, ACT, L the exclusive leading provider of market research reports published research report on “Global Cardiac Catheters Market Insights, Forecast to 2026”. The Global Cardiac Catheters Market Report 2020 is a professional and in-depth study on the current state of the Cardiac

OpenPR | January 16, 2021

Cardinal Health (CAH) Presents At 39th Annual JPMorgan Virtual Healthcare Conference - Slideshow

The following slide deck was published by Cardinal Health, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | January 15, 2021

Read More 'CAH' Stories Here

CAH Price Returns

1-mo 3.89%
3-mo 22.22%
6-mo 3.13%
1-year 6.75%
3-year -17.30%
5-year -20.03%
YTD 3.14%
2020 10.09%
2019 18.04%
2018 -24.50%
2017 -12.65%
2016 -17.53%

CAH Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full CAH Dividend History

Continue Researching CAH

Want to see what other sources are saying about Cardinal Health Inc's financials and stock price? Try the links below:

Cardinal Health Inc (CAH) Stock Price | Nasdaq
Cardinal Health Inc (CAH) Stock Quote, History and News - Yahoo Finance
Cardinal Health Inc (CAH) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8681 seconds.